We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Kimberly-Clark's Kenvue Acquisition Unlock Long-Term Growth?
Read MoreHide Full Article
Key Takeaways
Kimberly-Clark's Kenvue acquisition unites 10 billion-dollar brands across personal care and healthcare.
KMB targets $2.1 billion in run-rate synergies, including $1.9 billion in cost savings within three years.
Kimberly-Clark's four-segment structure aims to boost regional execution and unlock new growth opportunities.
Kimberly-Clark Corporation (KMB - Free Report) has taken a major step toward strengthening its position in the global consumer health and wellness market. The company completed the acquisition of Kenvue, bringing together established brands across personal care and healthcare categories. The combination expands Kimberly-Clark's product portfolio, geographic reach and opportunities for long-term growth.
The combined business houses 10 billion-dollar brands, including Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex and Scott. Serving consumers in more than 175 countries, the company has a stronger presence across baby care, women's health, active aging and everyday healthcare. This diversified portfolio positions Kimberly-Clark to capitalize on rising demand for science-backed products in the global health and wellness market, where annual consumer spending exceeds $500 billion.
A key financial opportunity from the acquisition is the anticipated $2.1 billion in run-rate synergies. Kimberly-Clark expects approximately $1.9 billion in cost savings within three years of closing. It also targets $500 million in incremental profit from revenue synergies, partially offset by $300 million in reinvestment, within four years. Its Powering Care growth engine is expected to support innovation, brand development and commercial execution across the expanded portfolio.
Following the acquisition, Kimberly-Clark will operate through four segments: North America, Asia Pacific Focus Markets, Europe, Middle East and Africa, and Enterprise Markets. The revised structure aims to strengthen regional execution and capture growth opportunities across diverse markets.
Under the transaction terms, Kenvue shareholders will receive $3.50 in cash and 0.14625 Kimberly-Clark shares for each share held. The acquisition expands Kimberly-Clark's scale and growth opportunities, while successful integration and timely synergy realization will remain key factors shaping its long-term performance.
The company has gained 13.2% in the past six months compared with the broader Consumer-Staples sector, the industry and the S&P 500 index’s growth of 8.4%, 11.8% and 2.9%, respectively.
KMB Stock's Past 6 Months' Performance
Image Source: Zacks Investment Research
Is KMB a Value Play Stock?
Shares of this Zacks Rank #5 (Sell) company currently trade at a forward 12-month P/E ratio of 15.52, below the industry and the sector’s average of 20.12 and 17.94, respectively. This valuation positions the stock at a modest discount relative to both its direct peers and the broader consumer staples sector.
The Zacks Consensus Estimate for BJ’s current fiscal-year sales and EPS indicates growth of 11.7% and 6.6%, respectively, from the prior-year reported levels. BJ’s Wholesale delivered a trailing four-quarter earnings surprise of 4.8%, on average.
Lamb Weston Holdings, Inc. (LW - Free Report) engages in the production, distribution and marketing of frozen potato products in the United States, Canada, Mexico and internationally. LW presently carries a Zacks Rank of 2. Lamb Weston delivered a trailing four-quarter earnings surprise of 22.1%, on average.
The Zacks Consensus Estimate for Lamb Weston’s current fiscal-year earnings indicates 7.6% growth from the year-ago numbers.
Mama's Creations, Inc. (MAMA - Free Report) manufactures and markets fresh deli-prepared foods in the United States. At present, MAMA holds a Zacks Rank of 2. Mama's Creations delivered a trailing four-quarter earnings surprise of 121.7%, on average.
The consensus estimate for Mama's Creations’ current fiscal-year sales and earnings implies growth of 30.3% and 66.7%, respectively, from the year-ago figures.
View the Zacks #1 Rank List
Image: Bigstock
Can Kimberly-Clark's Kenvue Acquisition Unlock Long-Term Growth?
Key Takeaways
Kimberly-Clark Corporation (KMB - Free Report) has taken a major step toward strengthening its position in the global consumer health and wellness market. The company completed the acquisition of Kenvue, bringing together established brands across personal care and healthcare categories. The combination expands Kimberly-Clark's product portfolio, geographic reach and opportunities for long-term growth.
The combined business houses 10 billion-dollar brands, including Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex and Scott. Serving consumers in more than 175 countries, the company has a stronger presence across baby care, women's health, active aging and everyday healthcare. This diversified portfolio positions Kimberly-Clark to capitalize on rising demand for science-backed products in the global health and wellness market, where annual consumer spending exceeds $500 billion.
A key financial opportunity from the acquisition is the anticipated $2.1 billion in run-rate synergies. Kimberly-Clark expects approximately $1.9 billion in cost savings within three years of closing. It also targets $500 million in incremental profit from revenue synergies, partially offset by $300 million in reinvestment, within four years. Its Powering Care growth engine is expected to support innovation, brand development and commercial execution across the expanded portfolio.
Following the acquisition, Kimberly-Clark will operate through four segments: North America, Asia Pacific Focus Markets, Europe, Middle East and Africa, and Enterprise Markets. The revised structure aims to strengthen regional execution and capture growth opportunities across diverse markets.
Under the transaction terms, Kenvue shareholders will receive $3.50 in cash and 0.14625 Kimberly-Clark shares for each share held. The acquisition expands Kimberly-Clark's scale and growth opportunities, while successful integration and timely synergy realization will remain key factors shaping its long-term performance.
Kimberly-Clark’s Zacks Rank & Share Price Performance
The company has gained 13.2% in the past six months compared with the broader Consumer-Staples sector, the industry and the S&P 500 index’s growth of 8.4%, 11.8% and 2.9%, respectively.
KMB Stock's Past 6 Months' Performance
Image Source: Zacks Investment Research
Is KMB a Value Play Stock?
Shares of this Zacks Rank #5 (Sell) company currently trade at a forward 12-month P/E ratio of 15.52, below the industry and the sector’s average of 20.12 and 17.94, respectively. This valuation positions the stock at a modest discount relative to both its direct peers and the broader consumer staples sector.
KMB P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Stocks to Consider
BJ’s Wholesale Club Holdings, Inc. (BJ - Free Report) is a leading membership-based warehouse club operator concentrated primarily in the eastern half of the United States. It currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for BJ’s current fiscal-year sales and EPS indicates growth of 11.7% and 6.6%, respectively, from the prior-year reported levels. BJ’s Wholesale delivered a trailing four-quarter earnings surprise of 4.8%, on average.
Lamb Weston Holdings, Inc. (LW - Free Report) engages in the production, distribution and marketing of frozen potato products in the United States, Canada, Mexico and internationally. LW presently carries a Zacks Rank of 2. Lamb Weston delivered a trailing four-quarter earnings surprise of 22.1%, on average.
The Zacks Consensus Estimate for Lamb Weston’s current fiscal-year earnings indicates 7.6% growth from the year-ago numbers.
Mama's Creations, Inc. (MAMA - Free Report) manufactures and markets fresh deli-prepared foods in the United States. At present, MAMA holds a Zacks Rank of 2. Mama's Creations delivered a trailing four-quarter earnings surprise of 121.7%, on average.
The consensus estimate for Mama's Creations’ current fiscal-year sales and earnings implies growth of 30.3% and 66.7%, respectively, from the year-ago figures.